A Study to Evaluate Investigational Agents With or Without Pembrolizumab (MK-3475) in Participants With Advanced Esophageal Cancer Previously Exposed to Programmed Cell Death 1 Protein (PD-1)/ Programmed Cell Death Ligand 1 (PD-L1) Treatment (MK-3475-06B)
PHASE1
This is a Phase 1/2, multicenter, randomized, open-label umbrella platform ...
Status
Recruiting
Location
University of Arizona Cancer Center-University of Arizona Cancer Center ( Site 4927)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Study to Evaluate the Safety and Efficacy of Uterine Blood Mesenchymal Stem Cells Injection for the Treatment of Severe Pneumonia Caused by Viruses
PHASE1
This study is a multicenter, randomized, double-blind, placebo-controlled c...
Status
Recruiting
Location
Ruijin Hospital affiliated to Shanghai Jiao Tong University